Aclarion, Inc. has released its Q3 2023 10-Q report, detailing significant revenue growth primarily from the UK market and strategic business developments. The report highlights increased revenue to $18,942, an improved gross profit, and a net loss of $(1,706,294) due to expanded sales and marketing efforts. The company anticipates continued revenue growth and increased R&amp;D expenses as it expands its insurance payor base and CLARITY Trial enrollment.

ACON

<p>Aclarion, Inc. 发布了其 2023 年第三季度 10-Q 报告，详细说明了主要来自英国市场的显著收入增长和战略业务发展。报告强调收入增加至 18,942 美元，毛利润改善，净亏损为 (1,706,294) 美元，原因是销售和市场推广力度的扩大。公司预计随着保险支付方基础和 CLARITY 试验入组的扩展，收入将持续增长，研发费用也将增加</p>

Aclarion 公司 SEC 10-Q 季度报告